Cannabis cannot be described accurately as harmless. Some cannabinoid medicines help with particular conditions, while cannabis can also impair driving, cause dependence and worsen some mental health symptoms. A useful assessment starts with the person, the product and the condition being treated.
This article replaces our earlier “mostly harmless” framing. That title overstated what research can establish. A study finding a low rate of one outcome does not measure every possible harm, and comparisons with alcohol do not settle whether cannabis is appropriate for an individual patient.
When is there evidence of a medical benefit?
Benefits need to be tied to a defined treatment. The US Food and Drug Administration has approved particular cannabinoid medicines; it has not approved the cannabis plant as a treatment for any disease. Approval of a medicine does not validate every flower, oil or edible containing a related compound. FDA: cannabis research and drug approval.
For chronic pain, the 2024 review from the US Agency for Healthcare Research and Quality found small improvements with some THC-containing products, alongside increased adverse effects. Much of the evidence involved neuropathic pain and relatively short follow-up. It does not establish that cannabis reliably treats all pain or remains beneficial indefinitely. AHRQ living review of cannabis for chronic pain.
For a patient, the next questions are practical: How much improvement is realistic? Does the evidence concern the proposed product? What alternatives have been tried? What result would justify continuing treatment? “Cannabis has medical uses” is the beginning of that conversation.
Immediate risks: impairment and distress
Cannabis can slow reactions and affect coordination, judgment and perception. Those effects matter when driving, riding a motorcycle or operating machinery. Combining cannabis with alcohol can increase impairment. Do not use a familiar product or a feeling of confidence as proof that you can drive safely. CDC: cannabis and driving.
Some people also experience anxiety, paranoia or disorientation. Cannabis use is associated with psychosis and schizophrenia, with stronger associations among people who start younger or use more often. These findings deserve particular attention in someone with a relevant mental health history. CDC: cannabis and mental health.
Our mental health article explains the difference between feeling temporarily calmer and having evidence that a treatment improves a psychiatric condition.
Dependence is a real possibility
Cannabis use disorder can involve using more than intended, repeated unsuccessful attempts to stop, cravings or continued use despite problems at home or work. Greater frequency of use increases risk. Needing help to change use is a health issue, not a character judgment. CDC: cannabis use disorder.
If use has become difficult to control, discuss the pattern with a clinician. Repeatedly scheduling a short break may leave the underlying problem unresolved. Our guide to tolerance breaks covers the limits of “reset” claims and what to prepare for when reducing use.
The route of use changes the questions
Smoking cannabis exposes the lungs to irritants and toxic substances. Research links it with cough, mucus production and bronchitis symptoms; the long-term evidence for some other lung diseases remains less certain. That uncertainty does not make smoke harmless. CDC: cannabis and lung health.
An oil, edible and flower are different products. Ask how the prescribed preparation is meant to be used, how its effects will be monitored and what to do if unwanted effects occur. Do not assume a change in route preserves the same amount or timing of effect.
Pregnancy is another reason for specific advice: THC can reach the fetus, and the CDC recommends avoiding cannabis during pregnancy. CDC: cannabis and pregnancy.
Bring these questions to a consultation
- What condition are we treating, and what improvement should I expect?
- Does the supporting study use this formulation and route?
- How do my medical history, medicines and alcohol use affect the decision?
- Which side effects should prompt a call or urgent assessment?
- When will we review whether treatment is helping?
Bring the product label and a list of medicines and supplements, rather than relying on a strain name. A useful treatment record includes the symptom being treated, changes in daily functioning and unwanted effects. It should help a clinician decide whether to continue, change or stop treatment.
For the differences between the main cannabinoids, read THC versus CBD. For an appointment in Thailand, our prescription guide explains how to prepare.
Editorial update: 6 September 2026. Educational information; individual treatment decisions require a qualified clinician.
